MiNK Therapeutics Inc. (NASDAQ: INKT)
$1.02
-0.0199 ( -1.91% ) 4.7K
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Market Data
Open
$1.02
Previous close
$1.04
Volume
4.7K
Market cap
$42.77M
Day range
$1.01 - $1.10
52 week range
$0.75 - $1.96
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 11 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 8-k | 8K-related | 11 | May 16, 2024 |
| 10-q | Quarterly Reports | 51 | May 14, 2024 |
| 8-k | 8K-related | 15 | May 14, 2024 |
| ars | Annual reports | 1 | Apr 30, 2024 |
| def | Proxies and info statements | 3 | Apr 29, 2024 |